Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
NexOptic Begins Announcing New Team Additions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Healthcare Biotechnology
Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a novel drug discovery and development platform based on signal peptides (SPs) to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, is a MUC1 SP-derived vaccine, which completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:VXL)

Vaxil Provides Update on Research Activities and Management Changes

GlobeNewswire August 2, 2023

Vaxil's Annual and Special Shareholders Meeting

GlobeNewswire April 24, 2023

Vaxil Provides Update on Research Activities

GlobeNewswire March 7, 2022

Vaxil's Annual and Special Shareholders Meeting

GlobeNewswire February 8, 2022

IIROC Trading Halt - VXL

PR Newswire January 4, 2022

Vaxil Bio (TSXV:VXL) makes strides with anti-cancer drug

Trevor Abes  January 4, 2022

IIROC Trading Resumption - VXL

PR Newswire January 4, 2022

Vaxil Provides Final Results on Its Previously Disclosed Research With Ben-Gurion University of the Negev

GlobeNewswire January 4, 2022

IIROC Trading Halt - VXL

PR Newswire January 4, 2022
View More News ››

Opinion & Analysis (TSXV:VXL)

Buzz on the Bullboards: A Fresh Start for Capital Markets in 2021?

Stockhouse Editorial January 7, 2021
View More Opinion ››

Bullboard Posts (TSXV:VXL)

RE:Is the company's lab ok after Hammas attack ???

the attack happened in kibbutz re'im, 5km from the gaza/israel border and far away from vaxil headquarters near tel aviv  
Vaxilman - November 15, 2023

Is the company's lab ok after Hammas attack ???

eom......
bligicka - October 12, 2023

NEWS

Vaxil Provides Update on Research Activities and Management Changes   August 02, 2023 17:00 ET | Source: Vaxil...
Red~One - August 2, 2023

RE:2023

Well, we traded 1.8 million shares today!! SO here is hoping!! GLA!
beenthere - February 17, 2023

2023

 All seriousness here, where do you guys see this going in 2023? I have tried contacting the company via emai and phone several...
anchorman1 - February 3, 2023

RE:RE:tax write off

 Pardon?
anchorman1 - February 2, 2023
View more Bullboard ››

Prospera Energy Inc

Prospera Energy Inc

Prospera Energy Inc. is a Canada-based energy company. The Company specializes in the exploration, development, and ...
View More »